Uses of TSYI-PA102 to improve osteoarthritis

TWI934428BPending Publication Date: 2026-08-01SYI BIOTECH CO LTD
View PDF 1 Cites 0 Cited by

Patent Information

Authority / Receiving Office
TW · TW
Patent Type
Patents
Current Assignee / Owner
SYI BIOTECH CO LTD
Filing Date
2025-01-21
Publication Date
2026-08-01

Smart Images

  • Figure TWG2TB001903773_001
    Figure TWG2TB001903773_001
  • Figure TWG2TB001903773_002
    Figure TWG2TB001903773_002
  • Figure TWG2TB001903773_003
    Figure TWG2TB001903773_003
Patent Text Reader

Abstract

This invention provides the use of Cordyceps militaris strain TSYI-PA102 for improving osteoarthritis, the accession number of which is BCRC 930232; osteoarthritis can be improved by applying Cordyceps militaris TSYI-PA102.
Need to check novelty before this filing date? Find Prior Art

Claims

1. Use of Cordyceps militaris TSYI-PA102 in the preparation of a composition for improving arthritis; wherein the composition is for oral administration.

2. The use as described in claim 1, wherein the Cordyceps militaris TSYI-PA102 is a deep-culture product.

3. The use as described in claim 1, wherein the arthritis is degenerative arthritis.

4. The use as described in claim 3, wherein the composition improves pain, inflammation, swelling, or loss of articular cartilage caused by osteoarthritis.

5. The use as described in claim 1, wherein the composition reduces the inflammatory indices IL-1β, IL-6 and TNF-α.

6. The use as described in claim 1, wherein the composition is a pharmaceutical composition, a nutritional supplement, or a health food.

7. The use as described in claim 1, wherein the composition comprises a pharmaceutically acceptable carrier, excipient, or diluent.

8. The use as described in claim 1, wherein the effective dose of TSYI-PA102 in the composition is 66 mg / kg body weight (mg / kg bw) or higher.

9. The use as described in claim 1, wherein the effective dose of TSYI-PA102 in the composition is 132 mg / kg body weight (mg / kg bw) or higher.

10. The use as described in claim 1, wherein the effective dose of TSYI-PA102 in the composition is 264 mg / kg body weight (mg / kg bw) or higher.